5-hydroxyindole potentiates human α7 nicotinic receptor-mediated responses and enhances acetylcholine-induced glutamate release in cerebellar slices

被引:95
作者
Zwart, R [1 ]
De Filippi, G [1 ]
Broad, LM [1 ]
McPhie, GI [1 ]
Pearson, KH [1 ]
Baldwinson, T [1 ]
Sher, E [1 ]
机构
[1] Eli Lilly & Co, Lilly Res Ctr Ltd, Windlesham GU20 6PH, Surrey, England
关键词
alpha 7 nicotinic receptor; Xenopus oocyte; cerebellar slice; 5-hydroxyindole; potentiation; modulation;
D O I
10.1016/S0028-3908(02)00094-1
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The effects of 5-hydroxyindole (5-HI) have been investigated on human alpha7 nicotinic acetylcholine receptors (nAChRs) expressed in Xenopus oocytes and GH4 cells, on native alpha7 nAChRs expressed by IMR-32 cells and on alpha7 nAChR-mediated events in mossy fibre-granule cell synapses in rat cerebellar slices. In oocytes expressing alpha7 nAChRs, 5-HI potentiated sub-maximal 60 muM ACh-induced ion currents in a concentration-dependent manner, the threshold effective concentration being 30 muM. 5-HI itself did not act as an agonist on alpha7 nAChRs. A maximum potentiation of 12 times the control was observed at 20 mM 5-HI. The effect of 1 mM 5-HI on the concentration-response curve for ACh revealed that 5-HI increased the potency as well as the efficacy of ACh on alpha7 nAChRs. 5-HI also potentiated alpha7-mediated increases in intracellular free calcium levels in both mammalian cells heterologously expressing human alpha7 nAChRs and in human IMR-32 neuroblastoma cells expressing native alpha7 nAChRs. At mossy fibre-granule cell synapses, application of 1 mM ACh induced glutamate-evoked excitory post-synaptic Currents (EPSCs). Co-application of 1 mM 5-HI with 1 mM ACh further increased the frequency of the EPSCs. The ACh-induced release, as well as the 5-HI-induced enhancement of release, were blocked by 1-10 nM methyllycaconitine or 200 nM alpha-bungarotoxin, demonstrating that both effects were mediated by presynaptic alpha7 nAChRs. The results demonstrate that responses mediated by alpha7 nAChRs are strongly potentiated by 5-HI. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:374 / 384
页数:11
相关论文
共 48 条
[21]   Activity of cytisine and its brominated isosteres on recombinant human α7, α4β2 and α4β4 nicotinic acetylcholine receptors [J].
Houlihan, LM ;
Slater, Y ;
Guerra, DL ;
Peng, JH ;
Kuo, YP ;
Lukas, RJ ;
Cassels, BK ;
Bermudez, I .
JOURNAL OF NEUROCHEMISTRY, 2001, 78 (05) :1029-1043
[22]   A NOVEL NICOTINIC AGONIST FACILITATES INDUCTION OF LONG-TERM POTENTIATION IN THE RAT HIPPOCAMPUS [J].
HUNTER, BE ;
DEFIEBRE, CM ;
PAPKE, RL ;
KEM, WR ;
MEYER, EM .
NEUROSCIENCE LETTERS, 1994, 168 (1-2) :130-134
[23]   COMPETITIVE AND NONCOMPETITIVE EFFECTS OF 5-HYDROXYINDOLE ON 5-HT3 RECEPTORS IN N1E-115 NEUROBLASTOMA-CELLS [J].
KOOYMAN, AR ;
VANHOOFT, JA ;
VANDERHEIJDEN, PML ;
VIJVERBERG, HPM .
BRITISH JOURNAL OF PHARMACOLOGY, 1994, 112 (02) :541-546
[24]   5-HYDROXYINDOLE SLOWS DESENSITIZATION OF THE 5-HT3 RECEPTOR-MEDIATED ION CURRENT IN N1E-115 NEUROBLASTOMA-CELLS [J].
KOOYMAN, AR ;
VANHOOFT, JA ;
VIJVERBERG, HPM .
BRITISH JOURNAL OF PHARMACOLOGY, 1993, 108 (02) :287-289
[25]   Ivermectin:: A positive allosteric effector of the α7 neuronal nicotinic acetylcholine receptor [J].
Krause, RM ;
Buisson, B ;
Bertrand, S ;
Corringer, PJ ;
Galzi, JL ;
Changeux, JP ;
Bertrand, D .
MOLECULAR PHARMACOLOGY, 1998, 53 (02) :283-294
[26]   Development of nicotinic drug therapy for cognitive disorders [J].
Levin, ED ;
Rezvani, AH .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 393 (1-3) :141-146
[27]  
Lloyd GK, 2000, J PHARMACOL EXP THER, V292, P461
[28]   Long-term potentiation of excitatory inputs to brain reward areas by nicotine [J].
Mansvelder, HD ;
McGehee, DS .
NEURON, 2000, 27 (02) :349-357
[29]  
Menzaghi F, 1997, J PHARMACOL EXP THER, V280, P393
[30]   (-)-spiro[1-azabicyclo[2.2.2]octane-3,5′-oxazolidin-2′-one], a conformationally restricted analogue of acetylcholine, is a highly selective full agonist at the α7 nicotinic acetylcholine receptor [J].
Mullen, G ;
Napier, J ;
Balestra, M ;
DeCory, T ;
Hale, G ;
Macor, J ;
Mack, R ;
Loch, J ;
Wu, E ;
Kover, A ;
Verhoest, P ;
Sampognaro, A ;
Phillips, E ;
Zhu, YY ;
Murray, R ;
Griffith, R ;
Blosser, J ;
Gurley, D ;
Machulskis, A ;
Zongrone, J ;
Rosen, A ;
Gordon, J .
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (22) :4045-4050